FIH (First-in-Human) strategy for reducing the development period of oral and injection drugs for clinical use
FIH (First-in-Human) strategy for reducing the development period of oral and injection drugs for clinical use
기업은 초기 개발 시 일정 지연을 자주 겪곤 합니다. 적합한 솔루션을 활용하면 속도, 품질, 위험완화 사이의 균형을 유지하면서 개발 일정을 단축할 수 있습니다.

Added Date:

2023-05-07

Filters:

Filter Category Filter Values
Specialty
  • Rare and Orphan drug
Language
  • Korean
Capability
  • Oral Solid Dose
  • Softgels
  • Steriles
market-category
  • Advanced therapy Cell and gene therapy
Asset Type
  • Webinar on-demand
Country
  • Korea
Region
  • Asia Pacific (APAC)
Market Category
  • Large molecule
  • Small molecule
Content Category
  • Collateral

Country Availability:


()

Gated Form:

None Set